EUVIMEDEUVIMED entdecken
Crossref

Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices

James Essell, Benjamin Derman, Barry Brooks, Gurjyot Doshi, Michael Kolodziej, Lavi Kwiatkowsky, Geoffrey Calkins, Mustafa Ascha

Journal of Clinical Pathways · 01.06.2025 · 11 (3)

DOI: 10.25270/jcp.2025.05.02 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pathways, online erschienen am 15.06.2025. Verfasst von James Essell und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted therapies have transformed the cancer treatment land­scape, marking a paradigm shift in cancer treatment. Bispecific antibodies (BsAbs), which engage two antigens simultaneously, represent the next ad­vancement in targeted immuno-oncologic treatment. However, as treatment modalities become more sophisticated so do their associated toxicities, necessi­tating more time-intensive and specialized approaches to toxicity management. This results in increased efforts by clinics to monitor patients, particularly in the absence of trainees or specialized staff, further adding to the cost of care associ­ated with such advanced treatments. Remote therapeutic monitoring (RTM) us­ing electronic patient-reported outcomes (ePROs) is a key component to cost-effective toxicity management for promising drugs such as BsAbs. It may enable greater access to BsAbs by reducing the burden of otherwise manual patient monitoring and symptom management. This manuscript reviews the use of BsAbs, barriers to their adoption in communi­ty clinics, and how RTM can streamline and support patient management to im­prove patient outcomes and reduce the cost of adopting these novel treatments.

Zitieren

APA

Essell, J., Derman, B., Brooks, B., Doshi, G., Kolodziej, M., Kwiatkowsky, L., Calkins, G., & Ascha, M. (2025). Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices. Journal of Clinical Pathways, 11(3). https://doi.org/10.25270/jcp.2025.05.02

Vancouver

Essell J, Derman B, Brooks B, Doshi G, Kolodziej M, Kwiatkowsky L, et al. Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices. Journal of Clinical Pathways. 2025;11(3). doi:10.25270/jcp.2025.05.02

BibTeX
@article{Essell2025,
  author = {Essell, James and Derman, Benjamin and Brooks, Barry and Doshi, Gurjyot and Kolodziej, Michael and Kwiatkowsky, Lavi and Calkins, Geoffrey and Ascha, Mustafa},
  title = {Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices},
  journal = {Journal of Clinical Pathways},
  year = {2025},
  volume = {11},
  number = {3},
  doi = {10.25270/jcp.2025.05.02}
}
Kostenlos starten →